Showing codes C9466 (Injection, benralizumab, 1 mg) — C9507 (Plasma, high titer covid-19 convalescent, each unit)

C9466 - Injection, benralizumab
Long description: Injection, benralizumab, 1 mg
Code added date: 20180401.
Code effective date: 20190101.
Pricing Indicator Code(s): 53 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: D (A code denoting Medicare coverage status).
HTML    PDF
C9467 - Inj rituximab hyaluronidase
Long description: Injection, rituximab and hyaluronidase, 10 mg
Code added date: 20180401.
Code effective date: 20190101.
Pricing Indicator Code(s): 53 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: D (A code denoting Medicare coverage status).
HTML    PDF
C9468 - Inj, factor ix, rebinyn
Long description: Injection, factor ix (antihemophilic factor, recombinant), glycopegylated, rebinyn, 1 i.u.
Code added date: 20180401.
Code effective date: 20190101.
Pricing Indicator Code(s): 53 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: D (A code denoting Medicare coverage status).
HTML    PDF
C9469 - Inj triamcinolone acetonide
Long description: Injection, triamcinolone acetonide, preservative-free, extended-release, microsphere formulation, 1 mg
Code added date: 20180401.
Code effective date: 20180701.
Pricing Indicator Code(s): 53 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: D (A code denoting Medicare coverage status).
HTML    PDF
C9470 - Aripiprazole lauroxil im
Long description: Injection, aripiprazole lauroxil, 1 mg
Code added date: 20160401.
Code effective date: 20170101.
Pricing Indicator Code(s): 53 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: D (A code denoting Medicare coverage status).
HTML    PDF
C9471 - Hymovis, 1 mg
Long description: Hyaluronan or derivative, hymovis, for intra-articular injection, 1 mg
Code added date: 20160401.
Code effective date: 20170101.
Pricing Indicator Code(s): 53 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: D (A code denoting Medicare coverage status).
HTML    PDF
C9472 - Inj talimogene laherparepvec
Long description: Injection, talimogene laherparepvec, 1 million plaque forming units (pfu)
Code added date: 20160401.
Code effective date: 20170101.
Pricing Indicator Code(s): 53 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: D (A code denoting Medicare coverage status).
HTML    PDF
C9473 - Injection, mepolizumab
Long description: Injection, mepolizumab, 1 mg
Code added date: 20160401.
Code effective date: 20170101.
Pricing Indicator Code(s): 53 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: D (A code denoting Medicare coverage status).
HTML    PDF
C9474 - Inj, irinotecan liposome
Long description: Injection, irinotecan liposome, 1 mg
Code added date: 20160401.
Code effective date: 20170101.
Pricing Indicator Code(s): 53 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: D (A code denoting Medicare coverage status).
HTML    PDF
C9475 - Injection, necitumumab
Long description: Injection, necitumumab, 1 mg
Code added date: 20160401.
Code effective date: 20170101.
Pricing Indicator Code(s): 53 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: D (A code denoting Medicare coverage status).
HTML    PDF
C9476 - Injection, daratumumab
Long description: Injection, daratumumab, 10 mg
Code added date: 20160701.
Code effective date: 20170101.
Pricing Indicator Code(s): 53 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: D (A code denoting Medicare coverage status).
HTML    PDF
C9477 - Injection, elotuzumab
Long description: Injection, elotuzumab, 1 mg
Code added date: 20160701.
Code effective date: 20170101.
Pricing Indicator Code(s): 53 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: D (A code denoting Medicare coverage status).
HTML    PDF
C9478 - Injection, sebelipase alfa
Long description: Injection, sebelipase alfa, 1 mg
Code added date: 20160701.
Code effective date: 20170101.
Pricing Indicator Code(s): 53 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: D (A code denoting Medicare coverage status).
HTML    PDF
C9479 - Instill, ciprofloxacin otic
Long description: Instillation, ciprofloxacin otic suspension, 6 mg
Code added date: 20160701.
Code effective date: 20170101.
Pricing Indicator Code(s): 53 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: D (A code denoting Medicare coverage status).
HTML    PDF
C9480 - Injection, trabectedin
Long description: Injection, trabectedin, 0.1 mg
Code added date: 20160701.
Code effective date: 20170101.
Pricing Indicator Code(s): 53 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: D (A code denoting Medicare coverage status).
HTML    PDF
C9481 - Injection, reslizumab
Long description: Injection, reslizumab, 1 mg
Code added date: 20161001.
Code effective date: 20170101.
Pricing Indicator Code(s): 53 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: D (A code denoting Medicare coverage status).
HTML    PDF
C9482 - Sotalol hydrochloride iv
Long description: Injection, sotalol hydrochloride, 1 mg
Code added date: 20161001.
Code effective date: 20161001.
Pricing Indicator Code(s): 53 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: D (A code denoting Medicare coverage status).
HTML    PDF
C9483 - Injection, atezolizumab
Long description: Injection, atezolizumab, 10 mg
Code added date: 20161001.
Code effective date: 20180101.
Pricing Indicator Code(s): 53 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: D (A code denoting Medicare coverage status).
HTML    PDF
C9484 - Injection, eteplirsen
Long description: Injection, eteplirsen, 10 mg
Code added date: 20170401.
Code effective date: 20180101.
Pricing Indicator Code(s): 53 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: D (A code denoting Medicare coverage status).
HTML    PDF
C9485 - Injection, olaratumab
Long description: Injection, olaratumab, 10 mg
Code added date: 20170401.
Code effective date: 20180101.
Pricing Indicator Code(s): 53 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: D (A code denoting Medicare coverage status).
HTML    PDF
C9486 - Inj, granisetron ext
Long description: Injection, granisetron extended release, 0.1 mg
Code added date: 20170401.
Code effective date: 20180101.
Pricing Indicator Code(s): 53 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: D (A code denoting Medicare coverage status).
HTML    PDF
C9487 - Ustekinumab iv inj, 1 mg
Long description: Ustekinumab, for intravenous injection, 1 mg
Code added date: 20170401.
Code effective date: 20170701.
Pricing Indicator Code(s): 53 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: D (A code denoting Medicare coverage status).
HTML    PDF
C9488 - Conivaptan hcl
Long description: Injection, conivaptan hydrochloride, 1 mg
Code added date: 20170401.
Code effective date: 20170401.
Pricing Indicator Code(s): 53 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: D (A code denoting Medicare coverage status).
HTML    PDF
C9489 - Injection, nusinersen
Long description: Injection, nusinersen, 0.1 mg
Code added date: 20170701.
Code effective date: 20180101.
Pricing Indicator Code(s): 53 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: D (A code denoting Medicare coverage status).
HTML    PDF
C9490 - Injection, bezlotoxumab
Long description: Injection, bezlotoxumab, 10 mg
Code added date: 20170701.
Code effective date: 20180101.
Pricing Indicator Code(s): 53 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: D (A code denoting Medicare coverage status).
HTML    PDF
C9491 - Injection, avelumab
Long description: Injection, avelumab, 10 mg
Code added date: 20171001.
Code effective date: 20180101.
Pricing Indicator Code(s): 53 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: D (A code denoting Medicare coverage status).
HTML    PDF
C9492 - Injection, durvalumab
Long description: Injection, durvalumab, 10 mg
Code added date: 20171001.
Code effective date: 20190101.
Pricing Indicator Code(s): 53 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: D (A code denoting Medicare coverage status).
HTML    PDF
C9493 - Injection, edaravone
Long description: Injection, edaravone, 1 mg
Code added date: 20171001.
Code effective date: 20190101.
Pricing Indicator Code(s): 53 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: D (A code denoting Medicare coverage status).
HTML    PDF
C9494 - Injection, ocrelizumab
Long description: Injection, ocrelizumab, 1 mg
Code added date: 20171001.
Code effective date: 20180101.
Pricing Indicator Code(s): 53 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: D (A code denoting Medicare coverage status).
HTML    PDF
C9497 - Loxapine, inhalation powder
Long description: Loxapine, inhalation powder, 10 mg
Code added date: 20140101.
Code effective date: 20190101.
Pricing Indicator Code(s): 53 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: D (A code denoting Medicare coverage status).
HTML    PDF
C9507 - Covid-19 convalescent plasma
Long description: Plasma, high titer covid-19 convalescent, each unit
Code added date: 20211228.
Code effective date: 20211228.
Pricing Indicator Code(s): 53 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: D (A code denoting Medicare coverage status).
HTML    PDF
Current Page # is: 47
Ones0123456789
Tens0123456789
Hundreds012